Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Health Care Supplies

BioSyntech Inc

+ Add to Watchlist


0.0100 USD 0.00000.00%

As of 20:10:00 ET on 04/16/2015.

Snapshot for BioSyntech Inc (BSYI)

Open: 0.0100 Day's Range: 0.0100 - 0.0100 Volume: 20,000
Previous Close: 0.0100 52wk Range: 0.0040 - 0.0290 1-Yr Rtn: +100.00%

Stock Chart for BSYI

No chart data available.
  • BSYI:US 0.0100
  • 1D
  • 1M
  • 1Y
Interactive BSYI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BSYI

Current P/E Ratio (ttm) -
Estimated P/E(03/2010) -
Relative P/E vs. SPX -
Earnings Per Share (CAD) (ttm) -0.1100
Est. EPS (CAD) (03/2010) -
Est. PEG Ratio -
Market Cap (M USD) 0.96
Shares Outstanding (M) 96.09
30 Day Average Volume 2,033
Price/Book (mrq) -
Price/Sale (ttm) 6.2721
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BSYI

No data available

Company Profile & Key Executives for BSYI

BioSyntech Inc. discovers, develops, and manufactures regenerative medicine products and therapeutic delivery systems. The Company's primary activity is tissue repair through its platform technology, BST-Gel. BioSyntech is seeking to license its products for regenerative medicine, orthopedics, reconstructive surgery, oncology, vaccines, and therapeutics to marketing partners worldwide.

Andre ArchimbaudChairmanJeanne M BertonisChief Executive Officer
Alberto RestrepoDirector:Medical Affairs
More Company Profile & Key Executives for BSYI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil